Europe Breast Cancer News
Europe
Europe Breast Cancer News is an EIN News Service for breast cancer professionals. Constantly updated news and information about Europe Breast Cancer.
Latest Europe Breast Cancer News
- Avastin Filed For Broader Breast Cancer Label In Europe For Use In Combination With Standard Chemotherapies 25 Nov 2009 15:31 GMT
... Avastin Filed For Broader Breast Cancer Label In Europe For Use In Combination With Standard Chemotherapies ... they have filed to extend the current European label of Avastin (bevacizumab) in patients with ...
- Cytori Completes Enrollment in International Breast Cancer Reconstruction Study; Interim Data to Be Presented Dec. 12 at San Antonio Breast Cancer Symposium 16 Nov 2009 12:31 GMT
... Cytori Completes Enrollment in International Breast Cancer Reconstruction Study; Interim Data to Be Presented Dec. ... were treated at seven centers in the European Union. The highest enrolling sites were Hospital ... lays the foundation for optimal reimbursement in Europe for Cell-Enriched Breast Reconstruction using the Celution®800 ...
- Cytori Completes Enrollment in International Breast Cancer Reconstruction Study; Interim Data to Be Presented Dec. 12 at 16 Nov 2009 13:30 GMT
... Cytori Completes Enrollment in International Breast Cancer Reconstruction Study; Interim Data to Be Presented Dec. ... were treated at seven centers in the European Union. The highest enrolling sites were Hospital ... lays the foundation for optimal reimbursement in Europe for Cell-Enriched Breast Reconstruction using the Celution800 ...
- Enrollment complete in Cytori Therapeutics' international breast cancer reconstruction study 16 Nov 2009 14:58 GMT
... (NASDAQ:CYTX) completed enrollment in a 70-patient, international breast cancer reconstruction study, RESTORE 2. The study is evaluating ... were treated at seven centers in the European Union. The highest enrolling sites were Hospital ... lays the foundation for optimal reimbursement in Europe for Cell-Enriched Breast Reconstruction using the Celution®800 ...
- Cytori Completes Enrollment In International Breast Cancer Reconstruction Study; Interim Data To Be Presented Dec. 12 18 Nov 2009 09:31 GMT
... who have undergone partial mastectomy for early breast cancer. Interim data on the first 32 patients ... were treated at seven centers in the European Union. The highest enrolling sites were Hospital ... lays the foundation for optimal reimbursement in Europe for Cell-Enriched Breast Reconstruction using the Celution®800 ...
- European Medical Advisory Committee Does Not Recommend Approval Of Avastin For Deadly Form Of Brain Cancer 20 Nov 2009 16:06 GMT
... European Medical Advisory Committee Does Not Recommend Approval ... have been filed for marketing authorisation in Europe, has issued a negative opinion relating to ... four common types of cancer: colorectal cancer, breast cancer, non-small cell lung cancer (NSCLC) and kidney ...
- European medical advisory committ... 23 Nov 2009 16:50 GMT
... have been filed for marketing authorisation in Europe, has issued a negative opinion relating to the approval ... new treatment option for physicians within the EU which would bring hope to GBM patients ... four common types of cancer: colorectal cancer, breast cancer, non-small cell lung cancer (NSCLC) and kidney ...
- Another cancer drug too dear for Britain: How bowel cancer victims are denied life-prolonging drug that's free in Europe 24 Nov 2009 01:33 GMT
... NHS which is available to patients across Europe and beyond. Trials show Avastin can extend life by ... drug while patients in virtually all other EU countries get the drug paid for. France, ... It contrasts with the fast-tracking of the breast cancer drug Herceptin after pressure from patients and the ...
- Another cancer drug too dear for Britain: How bowel cancer victims are denied life-prolonging care that's free in Europe 24 Nov 2009 03:03 GMT
... NHS which is available to patients across Europe and beyond. Trials show Avastin can extend life by ... drug while patients in virtually all other EU countries get the drug paid for. France, ... It contrasts with the fast-tracking of the breast cancer drug Herceptin after pressure from patients and the ...
- Another cancer drug too dear for UK: Bowel cancer victims denied life-extending care that's free in Europe 24 Nov 2009 09:17 GMT
... NHS which is available to patients across Europe and beyond. Trials show Avastin can extend life by ... drug while patients in virtually all other EU countries get the drug paid for. France, ... It contrasts with the fast-tracking of the breast cancer drug Herceptin after pressure from patients and the ...
- Health-Care Debate Linked to Risk of Dying in US and Europe 22 Nov 2009 01:52 GMT
... percent less. "The differences between U.S. and Europe in health care expenditures could not be ... billions of dollars being spent over our European counterparts after matching population sizes." Tough health ... are possible for women. The risks for breast cancer are lower in the U.S. For 50-, 60- ...
- European medical advisory committee does not recommend approval of Avastin 21 Nov 2009 11:33 GMT
... new treatment option for physicians within the EU which would bring hope to GBM patients ... types of cancer. It is approved in Europe for the treatment of the advanced stages of four common ... four common types of cancer: colorectal cancer, breast cancer, non-small cell lung cancer (NSCLC) and kidney ...
- New Markers of Prognosis for Cancer Therapies Highlighted 18 Nov 2009 20:52 GMT
... prognosis associated with metastatic and HER2 positive breast cancers, renal cell carcinoma and other advanced solid ... cancer, ovarian cancer, head and neck cancer, breast cancer and colon cancer, but no mutations were ... stimulate translational and clinical cancer research in Europe to improve the management of cancer and ...
- Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 23 Nov 2009 20:30 GMT
... cancer patients in the United States (U.S.), Europe, Switzerland, Canada and Australia. More information on ... producer approved in both the U.S. and European Union (EU), and works by raising and ... and men receiving hormone therapy for either breast cancer or prostate cancer. On October 2009, the FDA ...
- Amgen Recognized for Best Pipeline and Best New Drug at Scrip... 23 Nov 2009 20:55 GMT
... cancer patients in the United States (U.S.), Europe, Switzerland, Canada and Australia. More information on ... producer approved in both the U.S. and European Union (EU), and works by raising and ... and men receiving hormone therapy for either breast cancer or prostate cancer. On October 2009, the FDA ...
- Advances in Molecular Drug Development Highlighted 16 Nov 2009 20:13 GMT
... of hsp70 as a novel therapy for breast cancer; various drug compounds that kill leukemia stem ... Service at 1-800-4-CANCER (1-800-422-6237). About EORTC The European Organisation for Research and Treatment of Cancer ... stimulate translational and clinical cancer research in Europe to improve the management of cancer and ...
- Boehringer Ingelheim and GlaxoSmi... 18 Nov 2009 14:10 GMT
... have today announced their support of The European Federation of Allergy and Airways Diseases Patients` ... published a comprehensive overview of COPD in Europe, the EFA Book on COPD in Europe: ... – more than HIV/AIDS or lung and breast cancer combined.1,3 Despite this, COPD remains a scarcely known, ...
- CQ Transcript: Sens. Alexander, Bond, Specter and Stabnenow on 'Fox News Sunday' 22 Nov 2009 19:53 GMT
... of women who have been diagnosed with breast cancer well before 50. And one very close friend ... was with a bunch of -- some Europeans and people from... KRISTOL: ... the Middle ... their policy about an antimissile defense in Europe, the thought was, “Well, down the line ...
- Boehringer Ingelheim and GlaxoSmithKline back EFA`s call for urgent improvements in care for people with lung disease this World COPD Day 18 Nov 2009 14:16 GMT
... have today announced their support of The European Federation of Allergy and Airways Diseases Patients` ... published a comprehensive overview of COPD in Europe, the EFA Book on COPD in Europe: ... – more than HIV/AIDS or lung and breast cancer combined. Despite this, COPD remains a scarcely known, ...
- Good and Bad Choices for Energy Policy and the Environmental Movement 2009-2010 16 Nov 2009 15:30 GMT
... Sun goes around the Earth. It took Europeans 2000 years to get over that one. ... (2009) Climate change and infectious diseases in Europe. The Lancet Infectious Diseases, 9(6):365-75. 3. Nordell ... Let’s take an example from far afield: breast cancer and pollution of the environment by synthetic chemicals ...
- New EACS guidelines address co-morbidities and diseases of age 17 Nov 2009 04:30 GMT
... The 2009 Treatment Guidelines published by the European AIDS Clinical Society (EACS) are considerably longer ... other anti-infectious agents”. Cancer screening recommendations cover breast cancer in women aged 50-70, cervical cancer in sexually ... to normalise and standardise patient care over Europe.” ...
- Merck Serono: CHMP Opinion for Erbitux in Advanced Non-Small Cell Lung Cancer 20 Nov 2009 11:11 GMT
... Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has adopted a negative ... Germany) is disappointed that NSCLC patients in Europe will not get to benefit from Erbitux. ... to 81% for melanoma and 75% for breast cancer.4 a FLEX: First-Line ErbituX in lung cancer ...
- Rory's road back to Dubai 16 Nov 2009 06:14 GMT
... end-of-season showpiece in the history of the European Tour. Impressively, most of the fireworks will ... professional in February's , at 18, became Europe's youngest ever winner in the By comparison, ... were diagnosed and then underwent treatment for breast cancer. Yet one suspects the recession also played ...
- Bliss 17 Nov 2009 18:30 GMT
... Premature birth is twice as common as breast cancer and more than twice as common as prostate ... in the UK is the highest in western Europe. ...
- MediGene AG Reports First Nine Months of 2009: Increase in Revenue and Reduction of Loss 17 Nov 2009 13:31 GMT
... the commercialization of the drug EligardÒ in Europe, amounted to 28.6 million EUR in the ... market authorization for Veregen® in the first European countries, marketing authorization granted in Germany * ... EndoTAGTM-1 for the treatment of triple receptor-negative breast cancer is expected during the first half of 2010. ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
bbc.co.uk:
healthday.com:
about.com: